Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory
نویسندگان
چکیده
منابع مشابه
Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory
The no reflow phenomenon can happen during elective or primary percutaneous coronary intervention. This phenomenon is thought to be a complex process involving multiple factors that eventually lead to microvascular obstruction and endothelial disruption. Key pathogenic components include distal atherothrombotic embolization, ischemic injury, reperfusion injury, and susceptibility of coronary mi...
متن کاملSociety of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory.
The interventional cardiologist makes a provisional diagnosis of the no-reflow phenomenon in the presence of an acute reduction in coronary flow despite a widely patent epicardial vessel during percutaneous coronary intervention (PCI). Its occurrence is recognized as a column of contrast arising distal to the original target stenosis that does not rapidly clear [1–3]. The precise pathophysiolog...
متن کاملAnaesthesia in the cardiac catheterization laboratory.
PURPOSE OF REVIEW Interventions in the cardiac catheterization laboratory (CCL) requiring anaesthetic expertise are becoming routine. These interventions involve a heterogeneous patient population and take place in an offsite location. This review aims to give an insight into anaesthetic issues surrounding certain interventions and the challenges encountered in an offsite location. RECENT FIN...
متن کاملPharmacotherapy in the cardiac catheterization laboratory: evolution and recent developments
Many recent innovations have been made in developing new antiplatelet and anticoagulant drugs in the last few years, with a total of nine new antithrombotic drugs approved by the Food and Drug Administration after the year 2000. This has revolutionized the medical therapy given to manage acute coronary syndrome and support cardiac catheterization. The concept of dual antiplatelet therapy has be...
متن کاملQuality measurement and improvement in the cardiac catheterization laboratory.
Case Presentation: A 46-year-old man with a past medical history significant for morbid obesity (body mass index of 66), hypertension, tobacco use, and dyslipidemia presented to an outside hospital with a non–STsegment elevation myocardial infarction and was transferred for coronary angiography. Femoral arterial access was obtained for an uncomplicated percutaneous intervention (PCI) with the u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Cardiology Reviews
سال: 2012
ISSN: 1573-403X
DOI: 10.2174/157340312803217148